Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
12 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Imbruvica“
Suchtreffer
Begriffe & Kennungen
Imbruvica · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenImbruvica · 4.8 · Summary for B-cell malignancies The safety profile is based on pooled data from 1 981 patients treated with IM
Eintrag öffnenImbruvica · 4.8 · Summary for B-cell malignancies The safety profile is based on pooled data from 1 981 patients treated with IM
Eintrag öffnenImbruvica · 4.8 · Summary for patients with previously untreated MCL who were eligible for ASCT The safety profile is based on d
Eintrag öffnenImbruvica · 4.8 · Summary for patients with previously untreated MCL who were eligible for ASCT The safety profile is based on d
Eintrag öffnenImbruvica · 4.8 · Summary of the safety profile The most commonly occurring adverse reactions (≥20%) were diarrhoea, neutropenia
Eintrag öffnenImbruvica · 4.8 · Summary of the safety profile The most commonly occurring adverse reactions (≥20%) were diarrhoea, neutropenia
Eintrag öffnenImbruvica · 4.8 · Table 2: Adverse reactions reported in clinical studies or during post marketing surveillance in patients with
Eintrag öffnenImbruvica · 4.8 · Table 2: Adverse reactions reported in clinical studies or during post marketing surveillance in patients with
Eintrag öffnenImbruvica · 4.8 · Table 3: Adverse reactions reported in the IMBRUVICA arm of the TRIANGLE Study†
Eintrag öffnenImbruvica · 4.8 · Tabulated list of adverse reactions Adverse reactions in patients treated with ibrutinib for B-cell malignanci
Eintrag öffnenImbruvica · 4.8 · † Frequencies are rounded to the nearest integer. * Terms required grouping. # Includes events with fatal outc
Eintrag öffnen